Skip to main content
Log in

Facioscapulohumeral Dystrophy: Case Report and Discussion

  • Electrodiagnostic Corner
  • Published:
HSS Journal

Abstract

Facioscapulohumeral dystrophy (FSHD) is often cited as the third most common form of muscular dystrophy. Therefore, it should be considered in patients with complaints of progressive weakness. We present the case of a man with facial, truncal, and leg weakness that initially sought medical attention for lower back pain. Electrodiagnostic testing revealed findings in the trapezius, serratus anterior, biceps, triceps, pectoralis major, tibialis anterior, and gastrocnemius muscles consistent with a myopathic disorder. Subsequent genetic testing identified a FSHD allele size consistent with a FSHD deletion mutation. Therefore, confirming the diagnosis of FSHD. Unfortunately, no effective treatments currently exist for FSHD. However, supportive measures involving physical therapy and the use of orthotics may aid in improving function and mobility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Landoyzy L, Dejerine J (1886) Contribution à l’étude de la myopathie atrophique progressive (myopathie atrophique progressive, à type scapulo-huméral). Comptes rendus de la Société de biologie 38(8):478–481

    Google Scholar 

  2. Kilmer DD, Abresch RT, McCrory MA et al (1995) Profiles of neuromuscular diseases. Facioscapulohumeral muscular dystrophy. Am J Phys Med Rehabil 74(5 Suppl):S131–S139

    Article  PubMed  CAS  Google Scholar 

  3. Uncini A, Galluzzi G, Di Muzio A et al (2002) Facioscapulohumeral muscular dystrophy presenting isolated monomelic lower limb atrophy. Report of two patients with and without 4q35 rearrangement. Neuromuscul Disord 12(9):874–877

    Article  PubMed  CAS  Google Scholar 

  4. Van Der Kooi AJ, Visser MC, Rosenberg N et al (2000) Extension of the clinical range of facioscapulohumeral dystrophy: report of six cases. J Neurol Neurosurg Psychiatry 69(1):114–116

    Article  PubMed  Google Scholar 

  5. Kissel JT (1999) Facioscapulohumeral dystrophy. Semin Neurol 19(1):35–43

    Article  PubMed  CAS  Google Scholar 

  6. Tawil R, Van Der Maarel SM (2006) Facioscapulohumeral muscular dystrophy. Muscle Nerve 34(1):1–15

    Article  PubMed  CAS  Google Scholar 

  7. Osborne RJ, Welle S, Venance SL et al (2007) Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 68(8):569–577

    Article  PubMed  CAS  Google Scholar 

  8. Fitzsimons RB, Gurwin EB, Bird AC (1987) Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications. Brain 110(3):631–648

    Article  PubMed  Google Scholar 

  9. Wijmenga C, Padberg GW, Moerer P et al (1991) Mapping of facioscapulohumeral muscular dystrophy gene to chromosome 4q35-qter by multipoint linkage analysis and in situ hybridization. Genomics 9(4):570–575

    Article  PubMed  CAS  Google Scholar 

  10. Hewitt JE, Lyle R, Clark LN, Valleley EM et al (1994) Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet 3(8):1287–1295

    Article  PubMed  CAS  Google Scholar 

  11. Upadhyaya M, Cooper DN (2002) Molecular diagnosis of facioscapulohumeral muscular dystrophy. Expert Rev Mol Diagn 2(2):160–171

    Article  PubMed  CAS  Google Scholar 

  12. Podnar S, Zidar J (2006) Sensitivity of motor unit potential analysis in facioscapulohumeral muscular dystrophy. Muscle Nerve 34(4):451–456

    Article  PubMed  Google Scholar 

  13. Stübgen JP (2007) Facioscapulohumeral muscular dystrophy. A quantitative electromyographic study. Electromyogr Clin Neurophysiol 47(3):175–182

    PubMed  Google Scholar 

  14. Reed P, Porter NC, Strong J et al (2006) Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy. Ann Neurol 59(2):289–297

    Article  PubMed  Google Scholar 

  15. Kissel JT, McDermott MP, Mendell JR et al (2001) Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy. Neurology 57(8):1434–1440

    PubMed  CAS  Google Scholar 

  16. Rose MR, Tawil R (2004) Drug treatment for facioscapulohumeral muscular dystrophy. Cochrane Database Syst Rev 2:CD002276

    PubMed  Google Scholar 

  17. Olsen DB, Ørngreen MC, Vissing J (2005) Aerobic training improves exercise performance in facioscapulohumeral muscular dystrophy. Neurology 64(6):1064–1066

    PubMed  Google Scholar 

  18. Morosetti R, Mirabella M, Gliubizzi C et al (2007) Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies. Stem Cells 25(12):3173–3182

    Article  PubMed  CAS  Google Scholar 

  19. Vilquin JT, Marolleau JP, Sacconi S et al (2005) Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients. Gene Ther 12(22):1651–1662

    Article  PubMed  CAS  Google Scholar 

  20. Lunt PW, Harper PS (1991) Genetic counselling in facioscapulohumeral muscular dystrophy. J Med Genet 28(10):655–664

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincenzo Castellano MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castellano, V., Feinberg, J. & Michaels, J. Facioscapulohumeral Dystrophy: Case Report and Discussion. HSS Jrnl 4, 175–179 (2008). https://doi.org/10.1007/s11420-008-9078-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11420-008-9078-3

Keywords

Navigation